Cost and Cost-Effectiveness of Increasing Access to Sterile Syringes and Needles as an HIV Prevention Intervention in the United States
Holtgrave D, Pinkerton S, Jones T, Lurie P, Vlahov D. Cost and Cost-Effectiveness of Increasing Access to Sterile Syringes and Needles as an HIV Prevention Intervention in the United States. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s133-s138. PMID: 9663636, DOI: 10.1097/00042560-199802001-00022.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV infectionHIV prevention interventionsSterile syringesPrevention interventionsIDUs' accessActive injection drug usersIllicit drug injectionPublic health decision makersSyringe exchange programsHealth decision makersHIV transmissionDrug injectionHIV preventionHypothetical cohortDrug usersMedical carePocket expenditureInfectionPharmacy salesProgram coverageLifetime costsHigh levelsSyringesUnited StatesUse of Sterile Syringes and Aseptic Drug Preparation Are Important Components of HIV Prevention Among Injection Drug Users
Jones T, Vlahov D. Use of Sterile Syringes and Aseptic Drug Preparation Are Important Components of HIV Prevention Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s1-s5. PMID: 9663616, DOI: 10.1097/00042560-199802001-00002.Commentaries, Editorials and Letters